Technical Analysis for MRKR - Marker Therapeutics, Inc.

Grade Last Price % Change Price Change
grade C 5.73 -0.35% -0.02
MRKR closed down 0.35 percent on Friday, May 17, 2019, on 51 percent of normal volume. It was able to find support at its 50 day moving average.

Earnings due: May 21

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Flat Up
See historical MRKR trend table...

Date Alert Name Type % Chg
50 DMA Support Bullish 0.00%
BB Squeeze Ended Range Expansion 0.00%
Crossed Above 50 DMA Bullish -0.35%
MACD Bullish Centerline Cross Bullish -0.35%
Bollinger Band Squeeze Range Contraction -0.35%
BB Squeeze + Upper Band Touch Range Contraction -0.35%
Upper Bollinger Band Touch Strength -0.35%
50 DMA Resistance Bearish 0.70%
Bollinger Band Squeeze Range Contraction 0.70%
Down 3 Days in a Row Weakness 0.70%

Older signals for MRKR ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, develops T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its cell therapy technology is based on the tumor-specific T cells that recognize tumor associated antigens and kill tumor cells expressing those targets. The company is also advancing various peptide- and gene-based immuno-therapeutics for the treatment of cancer and metastatic disease, including its Folate Receptor Alpha program (TPIV200) for breast and ovarian cancers and HER2/neu+ peptide antigen program (TPIV100/110) in Phase II clinical trials. In addition, it develops a proprietary DNA expression technology, known as PolyStart, to improve the ability of the cellular immune system to recognize and destroy diseased cells. Marker Therapeutics, Inc. is headquartered in Houston, Texas.
Medicine Cancer Immunology Treatment Of Cancer Immunotherapy Oncology Immune System Cancer Treatments Virotherapy Tumor Cancer Immunotherapy Immunotherapies Cell Therapy Solid Tumor Hematological Malignancies T Cell
Is MRKR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 13.55
52 Week Low 3.33
Average Volume 370,146
200-Day Moving Average 6.7866
50-Day Moving Average 5.728
20-Day Moving Average 5.451
10-Day Moving Average 5.659
Average True Range 0.3142
ADX 23.63
+DI 20.8227
-DI 12.0273
Chandelier Exit (Long, 3 ATRs ) 5.1374
Chandelier Exit (Short, 3 ATRs ) 5.9526
Upper Bollinger Band 5.9456
Lower Bollinger Band 4.9564
Percent B (%b) 0.78
BandWidth 18.147129
MACD Line 0.0171
MACD Signal Line -0.0423
MACD Histogram 0.0595
Fundamentals Value
Market Cap 58.21 Million
Num Shares 10.2 Million
EPS -1.02
Price-to-Earnings (P/E) Ratio -5.62
Price-to-Sales 0.00
Price-to-Book 3.74
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.08
Resistance 3 (R3) 6.07 5.96 6.02
Resistance 2 (R2) 5.96 5.87 5.96 6.00
Resistance 1 (R1) 5.84 5.81 5.90 5.85 5.98
Pivot Point 5.73 5.73 5.76 5.73 5.73
Support 1 (S1) 5.61 5.64 5.67 5.62 5.48
Support 2 (S2) 5.50 5.58 5.50 5.46
Support 3 (S3) 5.38 5.50 5.44
Support 4 (S4) 5.39